Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Establishment and characterization of a CD95 (Fas/Apo-1)-negative myeloma cell line.

Acta haematologica - 1 Jan 1999

Kuribayashi N, Hata H, Yoshida M, Sonoki T, Nagasaki A, Kimura T, Harada N, Matsuzaki H

Abstract excerpt

Although expression of CD95 (Fas/Apo-1) on myeloma cells has been reported, its significance is not clearly understood. We established a myeloma cell line, KHM-11ad (11ad), from a parental cell line, KHM-11, by collecting cells adhered to a plastic dish. KHM-11 cells have been reported to be positive for CD45 and CD95 (Fas/Apo1), and negative for a myelomonocytic antigen, CD13. Interestingly, CD95 was not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Melphalan
Share to Antigens, Surface
Share to Antineoplastic Agents, Alkylating

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to bcl-X Protein

Share to Cell Culture Techniques

Share to fas Receptor

Share to Multiple Myeloma

Share to Proto-Oncogene Proteins c-bcl-2

Source

Identifiers

PMID: 10352328
DOI: 10.1159/000040935

Genes

PAM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Establishment and characterization of a CD95 (Fas/Apo-1)-negative myeloma cell line.PMID 10352328Read ↗

Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.Semantic proximity Read ↗

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cellsSemantic proximity Read ↗

Bone Marrow Stroma Confers Resistance to Apo2 Ligand/TRAIL in Multiple Myeloma in Part by Regulating c-FLIPSemantic proximity Read ↗

Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.Semantic proximity Read ↗

Mcl-1L cleavage is involved in TRAIL-R1– and TRAIL-R2–mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cellsSemantic proximity Read ↗

Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma.Semantic proximity Read ↗

Modulation of fas-mediated apoptosis in osteosarcoma cell lines.Semantic proximity Read ↗

A recessive mutant of the U937 cell line acquired resistance to anti-Fas and anti-p55 tumor necrosis factor receptor antibody-induced apoptosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.